BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 12375015)

  • 1. Expression of drug resistance gene products during progression of lung carcinomas.
    Mattern J; Koomägi R; Volm M
    Oncol Rep; 2002; 9(6):1181-4. PubMed ID: 12375015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
    Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
    Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Multidrug resistance and its relationship with neuroendocrine differentiation in non-small cell lung carcinoma].
    Yu SP; Xiong YY; Tian SF
    Zhonghua Jie He He Hu Xi Za Zhi; 2003 Mar; 26(3):165-8. PubMed ID: 12816683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of multidrug resistance 1 and glutathione-S-transferase-Pi protein in nasopharyngeal carcinoma.
    Chen CL; Sheen TS; Lou IU; Huang AC
    Hum Pathol; 2001 Nov; 32(11):1240-4. PubMed ID: 11727264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Correlation analysis among expression of ERCC-1, metallothionein, p53 and platinum resistance and prognosis in advanced non-small cell lung cancer].
    Huang PY; Liang XM; Lin SX; Luo RZ; Hou JH; Zhang L
    Ai Zheng; 2004 Jul; 23(7):845-50. PubMed ID: 15248926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical expression of glutathione transferase-pi in untreated primary non-small-cell lung cancer.
    Arai T; Yasuda Y; Takaya T; Hayakawa K; Toshima S; Shibuya C; Kashiki Y; Yoshimi N; Shibayama M
    Cancer Detect Prev; 2000; 24(3):252-7. PubMed ID: 10975287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of multidrug resistance-related proteins p-glycoprotein, glutathione-s-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
    Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
    Hepatogastroenterology; 2008; 55(86-87):1530-6. PubMed ID: 19102336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of multidrug resistance by small interfering double-stranded RNAs in ovarian cancer cells.
    Zhang T; Guan M; Jin HY; Lu Y
    Gynecol Oncol; 2005 May; 97(2):501-7. PubMed ID: 15863151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of anionic glutathione-S-transferase and P-glycoprotein genes in human tissues and tumors.
    Moscow JA; Fairchild CR; Madden MJ; Ransom DT; Wieand HS; O'Brien EE; Poplack DG; Cossman J; Myers CE; Cowan KH
    Cancer Res; 1989 Mar; 49(6):1422-8. PubMed ID: 2466554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression and significance of MRP, GST-pi, Topo IIalpha, and LRP in gastric carcinoma].
    Yu DQ; Yi YF
    Ai Zheng; 2003 May; 22(5):496-9. PubMed ID: 12753710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Placental isoform glutathione S-transferase and P-glycoprotein expression in advanced nonsmall cell lung cancer: association with response to treatment and survival.
    Vlachogeorgos GS; Manali ED; Blana E; Legaki S; Karagiannidis N; Polychronopoulos VS; Roussos C
    Cancer; 2008 Dec; 114(6):519-26. PubMed ID: 19006072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human renal UOK130 tumor cells: a drug resistant cell line with highly selective over-expression of glutathione S-transferase-pi isozyme.
    Wang W; Liu G; Zheng J
    Eur J Pharmacol; 2007 Jul; 568(1-3):61-7. PubMed ID: 17509556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associated expression of protein kinase C with resistance to doxorubicin in human lung cancer.
    Volm M; Pommerenke EW
    Anticancer Res; 1995; 15(2):463-6. PubMed ID: 7763022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular predictive factors for the drug response of lung cancer.
    Volm M; Rittgen W
    Anticancer Res; 2000; 20(5B):3449-58. PubMed ID: 11131647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of glutathione S-transferase pi and glutathione synthase correlates with survival in early stage non-small cell carcinomas of the lung.
    Allen TC; Granville LA; Cagle PT; Haque A; Zander DS; Barrios R
    Hum Pathol; 2007 Feb; 38(2):220-7. PubMed ID: 17234469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinoblastoma (Rb) protein expression and resistance in squamous cell lung carcinomas.
    Volm M; Stammler G
    Anticancer Res; 1996; 16(2):891-4. PubMed ID: 8687146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutathione-S transferase-pi expression in non small cell lung cancer in the assessment of response to chemotherapy.
    Unsal M; Akpolat I; Kandemir B
    Saudi Med J; 2003 May; 24(5):493-8. PubMed ID: 12847624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutathione S-transferase-pi in malignant tissues and plasma of human colorectal and gastric cancers.
    Doğru-Abbasoğlu S; Mutlu-Türkoğlu U; Türkoğlu S; Erbil Y; Barbaros U; Uysal M; Aykaç-Toker G
    J Cancer Res Clin Oncol; 2002 Feb; 128(2):91-5. PubMed ID: 11862479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple resistance mechanisms in acute nonlymphoblastic leukemia (ANLL).
    Sauerbrey A; Zintl F; Hermann J; Volm M
    Anticancer Res; 1998; 18(2B):1231-6. PubMed ID: 9615793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of several resistance mechanisms in untreated human kidney and lung carcinomas.
    Volm M; Mattern J; Efferth T; Pommerenke EW
    Anticancer Res; 1992; 12(4):1063-7. PubMed ID: 1354430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.